首页> 外文期刊>American journal of medical genetics, Part A >Severe hypertension-An infantile feature of Jansen metaphyseal chondrodysplasia?
【24h】

Severe hypertension-An infantile feature of Jansen metaphyseal chondrodysplasia?

机译:严重的高血压 - Jansen Metaphyseal软骨细胞普拉西亚的婴儿功能?

获取原文
获取原文并翻译 | 示例
           

摘要

Jansen metaphyseal chondrodysplasia (JMC) is a rare autosomal dominant skeletal dysplasia caused by gain-of-function mutations in the parathyroid hormone receptor 1 gene, PTH1R. We report on a patient presenting in the neonatal period with clinical signs of JMC in addition to severe hypertension. A pathogenic mutation in PTH1R was demonstrated, but investigations for hypertension yielded normal results. Hypertension has not been previously associated with JMC. Given aberration of the parathyroid hormone (PTH)/parathyroid-related protein pathway is the underlying pathogenic mechanism attributed to JMC, and also given evidence that hyperparathyroidism plays an important role in blood pressure homeostasis, we propose that hypertension is a hitherto unrecognized feature of JMC.
机译:Jansen Metaphyseal Chondrodysplasia(JMC)是一种稀有的常染色体显性骨骼发育不良,由甲状旁腺激素受体1基因,PTH1R中的功能性突变引起。 我们报告了在新生儿期间的患者,除了严重的高血压外,JMC的临床症状。 对PTH1R的致病性突变进行了说明,但高血压的研究产生了正常的结果。 高血压先前尚未与JMC相关联。 鉴于甲状旁腺激素(PTH)/甲状旁腺相关蛋白质途径的差异是归因于JMC的潜在病原机制,并且还给出了甲状旁腺功能亢进在血压稳态中发挥着重要作用的证据,我们提出了高血压是JMC的迄今为止无法识别的特征 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号